• Citer

Phase I study of lapatinib (L) and temozolomide (T) combination for the treatment of progressive brain metastases (BM) in HER2-positive metastatic breast cancer patients (Pts) (LAPTEM, LAP 111172)

par de Azambuja, Evandro ;Lemort, Marc ;Rossari, José ;Moulin, C;Buttice, A;D'Hondt, Veronique ;Lebrun, Fabienne;Lalami, Yassine ;Cardoso, Fatima ;Sotiriou, Christos ;Gil, Thierry ;Devriendt, Daniel ;Marinus, W.;Paesmans, Marianne ;Piccart-Gebhart, Martine ;Awada, Ahmad
Référence ASCO Annual meeting 2011(June 2011: Chicago, IL, USA), J Clin Oncol, ASCO Annual Meeting Proceedings, Vol. 29, 15 Suppl, Part I, page (62)
Publication Publié, 2011-06

Abstract de conférence

• Détails
• Contenu

Titre:	Phase I study of lapatinib (L) and temozolomide (T) combination for the treatment of progressive brain metastases (BM) in HER2-positive metastatic breast cancer patients (Pts) (LAPTEM, LAP 111172)
Auteur:	de Azambuja, Evandro; Lemort, Marc; Rossari, José; Moulin, C; Buttice, A; D'Hondt, Veronique; Lebrun, Fabienne; Lalami, Yassine; Cardoso, Fatima; Sotiriou, Christos; Gil, Thierry; Devriendt, Daniel; Marinus, W.; Paesmans, Marianne; Piccart-Gebhart, Martine; Awada, Ahmad
Informations sur la publication:	ASCO Annual meeting 2011(June 2011: Chicago, IL, USA), J Clin Oncol, ASCO Annual Meeting Proceedings, Vol. 29, 15 Suppl, Part I, page (62)
Statut de publication:	Publié, 2011-06
Sujet CREF:	Cancérologie
	Médecine pathologie humaine
Langue:	Anglais